Search is Powered by Google
Public Health News

How Europe's 'Precautionary Principle' Interacts With Cutting-Edge Technology

Main Category: Public Health
Also Included In: Conferences
Article Date: 15 May 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

BusinessWeek magazine claims the $60 billion international beauty products industry is "making a big bet on nanotech." Today, nearly a hundred cosmetics are in the Project on Emerging Nanotechnologies online inventory of products identified by manufacturers as containing nanomaterials.

Critical to the success of nanotechnology cosmetics is consumer confidence in their safety. In Europe, regulators and companies are attempting to apply "The Precautionary Principle" across all sectors.

How does a company like Paris-based cosmetics leader L'Oreal - which ranks No. 6 among nanotechnology patent holders in the U.S.- apply "The Precautionary Principle" to nanotechnology cosmetic products? What specific safety tests and post-market surveillance measures are used? How do U.S. and European regulations differ when applied to nanotechnology products? How does L'Oreal communicate with customers about this cutting-edge technology?

Scientists from L'Oreal will discuss these questions and more at a program on Thursday, June 5, 2008, in the auditorium of the Woodrow Wilson International Center for Scholars in Washington, DC.

Webcast LIVE at http://www.wilsoncenter.org/

What: Small is Beautiful: A European View of Nanotechnology Cosmetics and Safety, from L'Oreal

Who: Dr. Francis Quinn, L'Oreal
Dr. Andrew Maynard, Chief Science Advisor, Project on Emerging Nanotechnologies

When: Thursday, June 5, 2008, 1:00 p.m. - 2:00 p.m.
(A light lunch will be available from 12:15 -12:45 p.m. in the 6th floor boardroom)

Where: Woodrow Wilson International Center for Scholars, 6th Floor Auditorium. Ronald Reagan Building and International Trade Center, 1300 Pennsylvania Avenue, NW, Washington, DC 20004.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

The Project on Emerging Nanotechnologies was launched in 2005 by the Wilson Center and The Pew Charitable Trusts. It is a partnership dedicated to helping business, governments, and the public anticipate and manage the possible health and environmental implications of nanotechnology.

About Nanotechnology

Nanotechnology is the ability to measure, see, manipulate and manufacture things usually between 1 and 100 nanometers. A nanometer is one billionth of a meter; a human hair is roughly 100,000 nanometers wide. In 2007, nanotechnology was incorporated into more than $88 billion in manufactured goods. Lux Research projects that figure will grow to $2.6 trillion by 2014, or about 15% of total global output.

Source: Colin Finan
Project on Emerging Nanotechnologies

Ad Banner - MD Consult - the most access to the best resources


Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar

Sign up to receive newsletters / news alerts
MedReader RSS Reader


Katrina's Health Aftermath image Katrina's Health Aftermath

The worst of Hurricane Katrina may be over, but thousands of evacuees from the Gulf coast still face an uncertain future. With the recovery underway, are we prepared for the next perfect storm...

Drug Interactions image Drug Interactions

Most people realize drugs have side effects. But did you know drugs can interact with other prescription drugs, over-the-counter medications, herbal supplements and sometimes even food...

View more videos...